239 related articles for article (PubMed ID: 30199703)
1. The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase.
Chen Z; Marcé P; Resende R; Alzari PM; Frasch AC; van den Elsen JMH; Crennell SJ; Watts AG
Eur J Med Chem; 2018 Oct; 158():25-33. PubMed ID: 30199703
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular docking and biological evaluation of novel phthaloyl derivatives of 3-amino-3-aryl propionic acids as inhibitors of Trypanosoma cruzi trans-sialidase.
Kashif M; Chacón-Vargas KF; López-Cedillo JC; Nogueda-Torres B; Paz-González AD; Ramírez-Moreno E; Agusti R; Uhrig ML; Reyes-Arellano A; Peralta-Cruz J; Ashfaq M; Rivera G
Eur J Med Chem; 2018 Aug; 156():252-268. PubMed ID: 30006170
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in trans-sialidase inhibitors of Trypanosoma cruzi.
Kashif M; Moreno-Herrera A; Lara-Ramirez EE; Ramírez-Moreno E; Bocanegra-García V; Ashfaq M; Rivera G
J Drug Target; 2017 Jul; 25(6):485-498. PubMed ID: 28140698
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
Miller BR; Roitberg AE
Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
[TBL] [Abstract][Full Text] [Related]
5. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
Neres J; Bryce RA; Douglas KT
Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
[TBL] [Abstract][Full Text] [Related]
6. Benzoic Acid Derivatives with Trypanocidal Activity: Enzymatic Analysis and Molecular Docking Studies toward Trans-Sialidase.
Kashif M; Moreno-Herrera A; Villalobos-Rocha JC; Nogueda-Torres B; Pérez-Villanueva J; Rodríguez-Villar K; Medina-Franco JL; de Andrade P; Carvalho I; Rivera G
Molecules; 2017 Oct; 22(11):. PubMed ID: 29084172
[TBL] [Abstract][Full Text] [Related]
7. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
Meinke S; Schroven A; Thiem J
Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
[TBL] [Abstract][Full Text] [Related]
8. Structure-Based Virtual Screening of New Benzoic Acid Derivatives as Trypanosoma cruzi Trans-sialidase Inhibitors.
Vázquez-Jiménez LK; Paz-González AD; Juárez-Saldivar A; Uhrig ML; Agusti R; Reyes-Arellano A; Nogueda-Torres B; Rivera G
Med Chem; 2021; 17(7):724-731. PubMed ID: 32370720
[TBL] [Abstract][Full Text] [Related]
9. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
Blume A; Neubacher B; Thiem J; Peters T
Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
[TBL] [Abstract][Full Text] [Related]
10. T rypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas' disease.
Dc-Rubin SS; Schenkman S
Cell Microbiol; 2012 Oct; 14(10):1522-30. PubMed ID: 22747789
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and enzymatic evaluation of 3-O-substituted aryl β-D-galactopyranosides as inhibitors of Trypanosoma cruzi trans-sialidase.
Silva BL; S Filho JD; Andrade P; Carvalho I; Alves RJ
Bioorg Med Chem Lett; 2014 Sep; 24(18):4529-4532. PubMed ID: 25149510
[TBL] [Abstract][Full Text] [Related]
12. α-Selective glycosylation affords mucin-related GalNAc amino acids and diketopiperazines active on Trypanosoma cruzi.
Martins-Teixeira MB; Campo VL; Biondo M; Sesti-Costa R; Carneiro ZA; Silva JS; Carvalho I
Bioorg Med Chem; 2013 Apr; 21(7):1978-87. PubMed ID: 23415086
[TBL] [Abstract][Full Text] [Related]
13. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
[TBL] [Abstract][Full Text] [Related]
14. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
15. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.
Kim JH; Ryu HW; Shim JH; Park KH; Withers SG
Chembiochem; 2009 Oct; 10(15):2475-9. PubMed ID: 19780074
[TBL] [Abstract][Full Text] [Related]
16. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections.
Leguizamón MS; Campetella O; Russomando G; Almiron M; Guillen I; Ganzález Cappa SM; Frasch AC
J Infect Dis; 1994 Dec; 170(6):1570-4. PubMed ID: 7995998
[TBL] [Abstract][Full Text] [Related]
17. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
Giorgi ME; de Lederkremer RM
Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.
Schormann N; Velu SE; Murugesan S; Senkovich O; Walker K; Chenna BC; Shinkre B; Desai A; Chattopadhyay D
Bioorg Med Chem; 2010 Jun; 18(11):4056-66. PubMed ID: 20452776
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
Arioka S; Sakagami M; Uematsu R; Yamaguchi H; Togame H; Takemoto H; Hinou H; Nishimura S
Bioorg Med Chem; 2010 Feb; 18(4):1633-40. PubMed ID: 20097567
[TBL] [Abstract][Full Text] [Related]
20. Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion.
Marchiori MF; Riul TB; Oliveira Bortot L; Andrade P; Junqueira GG; Foca G; Doti N; Ruvo M; Dias-Baruffi M; Carvalho I; Campo VL
Bioorg Med Chem; 2017 Nov; 25(21):6049-6059. PubMed ID: 29032929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]